Search Results

There are 6122 results for: content related to: Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis

  1. You have free access to this content
    Splanchnic vein thrombosis in myeloproliferative neoplasms

    British Journal of Haematology

    Volume 162, Issue 6, September 2013, Pages: 730–747, Mallika Sekhar, Kathryn McVinnie and Andrew K. Burroughs

    Version of Record online : 15 JUL 2013, DOI: 10.1111/bjh.12461

  2. You have free access to this content
    The JAK2V617F mutation and thrombosis

    British Journal of Haematology

    Volume 143, Issue 3, November 2008, Pages: 307–320, S. K. Austin and J. R. Lambert

    Version of Record online : 30 MAY 2008, DOI: 10.1111/j.1365-2141.2008.07258.x

  3. Prevalence of overt myeloproliferative neoplasms and JAK2 V617F mutation in Korean patients with splanchnic vein thrombosis

    International Journal of Laboratory Hematology

    Volume 33, Issue 5, October 2011, Pages: 471–476, E.-H. YOO, J.-H. JANG, K.-J. PARK, G.-Y. GWAK, H.-J. KIM, S.-H. KIM and D.-K. KIM

    Version of Record online : 24 MAR 2011, DOI: 10.1111/j.1751-553X.2011.01308.x

  4. You have free access to this content
    Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders

    Journal of Thrombosis and Haemostasis

    Volume 5, Issue 4, April 2007, Pages: 708–714, V. DE STEFANO, A. FIORINI, E. ROSSI, T. ZA, G. FARINA, P. CHIUSOLO, S. SICA and G. LEONE

    Version of Record online : 29 JAN 2007, DOI: 10.1111/j.1538-7836.2007.02424.x

  5. You have free access to this content
    The role of serum erythropoietin level and jak2 v617f allele burden in the diagnosis of polycythaemia vera

    British Journal of Haematology

    Volume 167, Issue 3, November 2014, Pages: 411–417, Àgueda Ancochea, Alberto Álvarez-Larrán, Cristian Morales-Indiano, Francesc García-Pallarols, Luz Martínez-Avilés, Anna Angona, Alicia Senín, Beatriz Bellosillo and Carles Besses

    Version of Record online : 18 JUL 2014, DOI: 10.1111/bjh.13047

  6. You have free access to this content
    The JAK2 exon 12 mutations: A comprehensive review

    American Journal of Hematology

    Volume 86, Issue 8, August 2011, Pages: 668–676, Linda M. Scott

    Version of Record online : 14 JUN 2011, DOI: 10.1002/ajh.22063

  7. You have free access to this content
    Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis

    British Journal of Haematology

    Joan How, Kathryn M. Trinkaus and Stephen T. Oh

    Version of Record online : 19 OCT 2017, DOI: 10.1111/bjh.14958

  8. Application of mutant JAK2V617F for in vitro generation of red blood cells

    Transfusion

    Volume 56, Issue 4, April 2016, Pages: 837–843, Sun Ah Lee, Ji Yeon Kim, Yongwook Choi, Yonggoo Kim and Hyun Ok Kim

    Version of Record online : 9 DEC 2015, DOI: 10.1111/trf.13431

  9. You have free access to this content
    JAK2-V617F mutation in cerebral venous thrombosis

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue 6, June 2009, Pages: 1039–1040, K. KOOPMAN, A. B. MULDER, J. DE KEYSER, G. J. LUIJCKX and J. VAN DER MEER

    Version of Record online : 26 MAR 2009, DOI: 10.1111/j.1538-7836.2009.03354.x

  10. You have free access to this content
    Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations

    British Journal of Haematology

    Volume 160, Issue 1, January 2013, Pages: 25–34, Anthony J. Bench, Helen E. White, Letizia Foroni, Anna L. Godfrey, Gareth Gerrard, Susanna Akiki, Abida Awan, Ian Carter, Andrea Goday-Fernandez, Stephen E. Langabeer, Tim Clench, Jordan Clark, Paul A. Evans, David Grimwade, Anna Schuh, Mary F. McMullin, Anthony R. Green, Claire N. Harrison and Nicholas C. P. Cross

    Version of Record online : 11 OCT 2012, DOI: 10.1111/bjh.12075

  11. You have free access to this content
    Advances in Understanding and Management of Myeloproliferative Neoplasms

    CA: A Cancer Journal for Clinicians

    Volume 59, Issue 3, May/June 2009, Pages: 171–191, Alessandro M. Vannucchi, Paola Guglielmelli and Ayalew Tefferi

    Version of Record online : 16 APR 2009, DOI: 10.3322/caac.20009

  12. You have free access to this content
    Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms

    British Journal of Haematology

    Volume 147, Issue 4, November 2009, Pages: 495–506, Lizz F. Grimwade, Lisa Happerfield, Colin Tristram, Gary McIntosh, Mark Rees, Anthony J. Bench, Elaine M. Boyd, Marie Hall, Amy Quinn, Nigel Piggott, Paul Scorer, Mike A. Scott and Wendy N. Erber

    Version of Record online : 31 AUG 2009, DOI: 10.1111/j.1365-2141.2009.07870.x

  13. You have free access to this content
    TET2 gene sequencing may be helpful for myeloproliferative neoplasm diagnosis

    British Journal of Haematology

    Volume 165, Issue 3, May 2014, Pages: 416–419, Emmanuelle Verger, Annalisa Andreoli, Christine Chomienne, Jean-Jacques Kiladjian and Bruno Cassinat

    Version of Record online : 16 JAN 2014, DOI: 10.1111/bjh.12738

  14. You have free access to this content
    JAK2V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events

    American Journal of Hematology

    Volume 89, Issue 5, May 2014, Pages: 517–523, Alberto Alvarez-Larrán, Beatriz Bellosillo, Arturo Pereira, Ana Kerguelen, Juan Carlos Hernández-Boluda, Luz Martínez-Avilés, Concepción Fernández-Rodríguez, Montse Gómez, Luis Lombardía, Anna Angona, Águeda Ancochea, Alicia Senín, Raquel Longarón, Blanca Navarro, María Collado and Carlos Besses

    Version of Record online : 21 FEB 2014, DOI: 10.1002/ajh.23676

  15. You have free access to this content
    Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population

    British Journal of Haematology

    Volume 160, Issue 1, January 2013, Pages: 70–79, Camilla Nielsen, Henrik S. Birgens, Børge G. Nordestgaard and Stig E. Bojesen

    Version of Record online : 1 NOV 2012, DOI: 10.1111/bjh.12099

  16. You have free access to this content
    MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients

    American Journal of Hematology

    Volume 93, Issue 1, January 2018, Pages: 100–106, Adrian P. Trifa, Claudia Bănescu, Anca S. Bojan, Cristian M. Voina, Ștefana Popa, Simona Vișan, Alina D. Ciubean, Florin Tripon, Delia Dima, Viola M. Popov, Ștefan C. Vesa, Mihaela Andreescu, Tünde Török-Vistai, Romeo G. Mihăilă, Nicoleta Berbec, Ioan Macarie, Andrei Coliţă, Maria Iordache, Alina C. Cătană, Marius F. Farcaș, Ciprian Tomuleasa, Kinga Vasile, Cristina Truică, Adriana Todincă, Lavinia Pop-Muntean, Raluca Manolache, Horia Bumbea, Ana-Maria Vlădăreanu, Mihaela Gaman, Cristina M. Ciufu and Radu A. Popp

    Version of Record online : 10 NOV 2017, DOI: 10.1002/ajh.24946

  17. Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates

    European Journal of Haematology

    Volume 84, Issue 6, June 2010, Pages: 518–524, Mrinal M. Patnaik, Ryan A. Knudson, Naseema Gangat, Curtis A. Hanson, Animesh Pardanani, Ayalew Tefferi and Rhett P. Ketterling

    Version of Record online : 11 MAR 2010, DOI: 10.1111/j.1600-0609.2010.01428.x

  18. You have full text access to this Open Access content
    Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1

    Journal of Cellular and Molecular Medicine

    Volume 13, Issue 2, February 2009, Pages: 215–237, Ayalew Tefferi

    Version of Record online : 23 OCT 2008, DOI: 10.1111/j.1582-4934.2008.00559.x

  19. You have free access to this content
    Molecular diagnostics of myeloproliferative neoplasms

    European Journal of Haematology

    Volume 95, Issue 4, October 2015, Pages: 270–279, Stephen E. Langabeer, Hajnalka Andrikovics, Julia Asp, Beatriz Bellosillo, Serge Carillo, Karl Haslam, Lasse Kjaer, Eric Lippert, Olivier Mansier, Elisabeth Oppliger Leibundgut, Melanie J. Percy, Naomi Porret, Lars Palmqvist, Jiri Schwarz, Mary F. McMullin, Susanne Schnittger, Niels Pallisgaard, Sylvie Hermouet and on behalf of the MPN&MPNr-EuroNet

    Version of Record online : 18 MAY 2015, DOI: 10.1111/ejh.12578

  20. You have free access to this content
    TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms – a multicentric study on 529 patients

    British Journal of Haematology

    Volume 174, Issue 2, July 2016, Pages: 218–226, Adrian P. Trifa, Claudia Bănescu, Mihaela Tevet, Anca Bojan, Delia Dima, Laura Urian, Tünde Török-Vistai, Viola M. Popov, Mihnea Zdrenghea, Ljubomir Petrov, Anca Vasilache, Meilin Murat, Daniela Georgescu, Mihaela Popescu, Oana Pătrinoiu, Marius Balea, Roxana Costache, Elena Coleș, Carmen Șaguna, Nicoleta Berbec, Ana-Maria Vlădăreanu, Romeo G. Mihăilă, Horia Bumbea, Andrei Cucuianu and Radu A. Popp

    Version of Record online : 7 APR 2016, DOI: 10.1111/bjh.14041